Biomatter

📍 Vilnius, Lithuania👥 36 employees💰 Last funded 2026
Biotechnology Research🌐 biomatter.com
Website LinkedIn
Biomatter is an enzyme design company creating previously impossible enzymes for health and sustainable manufacturing applications. We partner with leading companies across food, chemicals, home care, agriculture, diagnostics, and therapeutics to deliver new enzyme molecules — designed with AI and Physics, built and tested in our lab, in weeks rather than years.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
Sweden
1
Investor activity2024–2026 · investors recorded per year
2024220261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Biomatter?
Biomatter has 3 investors on record on gritt.io and 2 late-stage investors.
When did Biomatter last raise funding?
The most recent investment in Biomatter recorded on gritt.io was in 2026.
What industry is Biomatter in?
Biomatter operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biomatter based?
Biomatter is headquartered in Vilnius, Lithuania.